277 related articles for article (PubMed ID: 32726650)
21. Emerging nanomedicines of paclitaxel for cancer treatment.
Chen Q; Xu S; Liu S; Wang Y; Liu G
J Control Release; 2022 Feb; 342():280-294. PubMed ID: 35016919
[TBL] [Abstract][Full Text] [Related]
22. Promising Nanomedicines of Shikonin for Cancer Therapy.
Yan C; Li Q; Sun Q; Yang L; Liu X; Zhao Y; Shi M; Li X; Luo K
Int J Nanomedicine; 2023; 18():1195-1218. PubMed ID: 36926681
[TBL] [Abstract][Full Text] [Related]
23. Lipid prodrug nanocarriers in cancer therapy.
Mura S; Bui DT; Couvreur P; Nicolas J
J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
[TBL] [Abstract][Full Text] [Related]
24. Lipophilic Prodrugs of SN38: Synthesis and in Vitro Characterization toward Oral Chemotherapy.
Bala V; Rao S; Li P; Wang S; Prestidge CA
Mol Pharm; 2016 Jan; 13(1):287-94. PubMed ID: 26623947
[TBL] [Abstract][Full Text] [Related]
25. Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery.
Huang L; Yang J; Wang T; Gao J; Xu D
J Nanobiotechnology; 2022 Jan; 20(1):49. PubMed ID: 35073914
[TBL] [Abstract][Full Text] [Related]
26. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
Garg T; Bhandari S; Rath G; Goyal AK
J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
[TBL] [Abstract][Full Text] [Related]
27. Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release.
Wang H; Wu J; Xie K; Fang T; Chen C; Xie H; Zhou L; Zheng S
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10567-10576. PubMed ID: 28271714
[TBL] [Abstract][Full Text] [Related]
28. Dual Stimuli-Responsive Polymer Prodrugs Quantitatively Loaded by Nanoparticles for Enhanced Cellular Internalization and Triggered Drug Release.
Huang M; Zhao K; Wang L; Lin S; Li J; Chen J; Zhao C; Ge Z
ACS Appl Mater Interfaces; 2016 May; 8(18):11226-36. PubMed ID: 27100328
[TBL] [Abstract][Full Text] [Related]
29. Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.
Wang H; Chen J; Xu C; Shi L; Tayier M; Zhou J; Zhang J; Wu J; Ye Z; Fang T; Han W
Theranostics; 2017; 7(15):3638-3652. PubMed ID: 29109766
[TBL] [Abstract][Full Text] [Related]
30. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
[TBL] [Abstract][Full Text] [Related]
31. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
Dening TJ; Rao S; Thomas N; Prestidge CA
J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
[TBL] [Abstract][Full Text] [Related]
32. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
33. Emerging nanoparticle platforms to improve the administration of glucocorticoids.
Tessier B; Tsapis N; Fattal E; Moine L
J Control Release; 2023 Jun; 358():273-292. PubMed ID: 37127077
[TBL] [Abstract][Full Text] [Related]
34. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
35. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE
Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
[TBL] [Abstract][Full Text] [Related]
36. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
37. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems.
Kratz F; Warnecke A
J Control Release; 2012 Dec; 164(2):221-35. PubMed ID: 22705248
[TBL] [Abstract][Full Text] [Related]
38. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in prodrug-based nanoparticle therapeutics.
Chen KJ; Plaunt AJ; Leifer FG; Kang JY; Cipolla D
Eur J Pharm Biopharm; 2021 Aug; 165():219-243. PubMed ID: 33979661
[TBL] [Abstract][Full Text] [Related]
40. Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.
Zhang HY; Sun CY; Adu-Frimpong M; Yu JN; Xu XM
Int J Pharm; 2019 Jan; 555():270-279. PubMed ID: 30471374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
